drugset / Trial / NCT03275974
Glutamine PET Imaging Colorectal Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
The clinical trial studies how well 11C-glutamine and 18F-FSPG positron emission tomography (PET) imaging works in detecting tumors in patients with metastatic colorectal cancer compared to standard imaging methods such as magnetic resonance imaging (MRI) or computed tomography (CT) scanning.
Timeline
- Start
- 2021-04-27
- Primary completion
- 2025-12-23
- Completion
- 2025-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 11C-Glutamine | Diagnostic / imaging agent | — | Intravenous |
| Subject | 18F-FSPG | Diagnostic / imaging agent | — | Intravenous |